Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025655500> ?p ?o ?g. }
- W3025655500 endingPage "2291" @default.
- W3025655500 startingPage "2291" @default.
- W3025655500 abstract "Complexes of Fe(III) that contain a triazacyclononane (TACN) macrocycle, two pendant hydroxyl groups, and a third ancillary pendant show promise as MRI contrast agents. The ancillary group plays an important role in tuning the solution relaxivity of the Fe(III) complex and leads to large changes in MRI contrast enhancement in mice. Two new Fe(III) complexes, one with a third coordinating hydroxypropyl pendant, Fe(L2), and one with an anionic non-coordinating sulfonate group, Fe(L1)(OH2), are compared. Both complexes have a deprotonated hydroxyl group at neutral pH and electrode potentials representative of a stabilized trivalent iron center. The r1 relaxivity of the Fe(L1)(OH2) complex is double that of the saturated complex, Fe(L2), at 4.7 T, 37 °C in buffered solutions. However, variable-temperature 17O-NMR experiments show that the inner-sphere water of Fe(L1)(OH2) does not exchange rapidly with bulk water under these conditions. The pendant sulfonate group in Fe(L1)(OH2) confers high solubility to the complex in comparison to Fe(L2) or previously studied analogues with benzyl groups. Dynamic MRI studies of the two complexes showed major differences in their pharmacokinetics clearance rates compared to an analogue containing a benzyl ancillary group. Rapid blood clearance and poor binding to serum albumin identify Fe(L1)(OH2) for development as an extracellular fluid contrast agent." @default.
- W3025655500 created "2020-05-21" @default.
- W3025655500 creator A5000840305 @default.
- W3025655500 creator A5011623946 @default.
- W3025655500 creator A5036803810 @default.
- W3025655500 creator A5041631994 @default.
- W3025655500 creator A5050648586 @default.
- W3025655500 creator A5054903525 @default.
- W3025655500 creator A5075438930 @default.
- W3025655500 date "2020-05-13" @default.
- W3025655500 modified "2023-10-05" @default.
- W3025655500 title "Modulating the Properties of Fe(III) Macrocyclic MRI Contrast Agents by Appending Sulfonate or Hydroxyl Groups" @default.
- W3025655500 cites W1871882069 @default.
- W3025655500 cites W1969043349 @default.
- W3025655500 cites W1969360633 @default.
- W3025655500 cites W1980440335 @default.
- W3025655500 cites W1981322694 @default.
- W3025655500 cites W1985067039 @default.
- W3025655500 cites W1994486737 @default.
- W3025655500 cites W1995976462 @default.
- W3025655500 cites W2009797358 @default.
- W3025655500 cites W2011762245 @default.
- W3025655500 cites W2013886665 @default.
- W3025655500 cites W2015775406 @default.
- W3025655500 cites W2017865509 @default.
- W3025655500 cites W2018517576 @default.
- W3025655500 cites W2023094848 @default.
- W3025655500 cites W2030003406 @default.
- W3025655500 cites W2033503179 @default.
- W3025655500 cites W2039124604 @default.
- W3025655500 cites W2044958633 @default.
- W3025655500 cites W2045440907 @default.
- W3025655500 cites W2048086807 @default.
- W3025655500 cites W2048495383 @default.
- W3025655500 cites W2055153445 @default.
- W3025655500 cites W2059205366 @default.
- W3025655500 cites W2064582130 @default.
- W3025655500 cites W2065983431 @default.
- W3025655500 cites W2067201855 @default.
- W3025655500 cites W2074490799 @default.
- W3025655500 cites W2074532371 @default.
- W3025655500 cites W2079687938 @default.
- W3025655500 cites W2081514177 @default.
- W3025655500 cites W2083321854 @default.
- W3025655500 cites W2091934527 @default.
- W3025655500 cites W2094652670 @default.
- W3025655500 cites W2099037802 @default.
- W3025655500 cites W2111481358 @default.
- W3025655500 cites W2127810894 @default.
- W3025655500 cites W2131350133 @default.
- W3025655500 cites W2132454074 @default.
- W3025655500 cites W2140213304 @default.
- W3025655500 cites W2140893236 @default.
- W3025655500 cites W2146343157 @default.
- W3025655500 cites W2152775093 @default.
- W3025655500 cites W2161136265 @default.
- W3025655500 cites W2161536039 @default.
- W3025655500 cites W2167590372 @default.
- W3025655500 cites W2196985026 @default.
- W3025655500 cites W2247895134 @default.
- W3025655500 cites W2252241287 @default.
- W3025655500 cites W2279704427 @default.
- W3025655500 cites W2314882532 @default.
- W3025655500 cites W2515055839 @default.
- W3025655500 cites W2518537146 @default.
- W3025655500 cites W2547229409 @default.
- W3025655500 cites W2555694436 @default.
- W3025655500 cites W263575074 @default.
- W3025655500 cites W2753466980 @default.
- W3025655500 cites W2767322424 @default.
- W3025655500 cites W2767931246 @default.
- W3025655500 cites W2784841869 @default.
- W3025655500 cites W2788087525 @default.
- W3025655500 cites W2788427744 @default.
- W3025655500 cites W2807676901 @default.
- W3025655500 cites W2890013071 @default.
- W3025655500 cites W2891299437 @default.
- W3025655500 cites W2896682297 @default.
- W3025655500 cites W2952762392 @default.
- W3025655500 cites W2959031274 @default.
- W3025655500 cites W2972224799 @default.
- W3025655500 cites W2995481085 @default.
- W3025655500 cites W2998986817 @default.
- W3025655500 cites W3011566364 @default.
- W3025655500 cites W4249509226 @default.
- W3025655500 cites W965227330 @default.
- W3025655500 cites W2083229842 @default.
- W3025655500 doi "https://doi.org/10.3390/molecules25102291" @default.
- W3025655500 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7288058" @default.
- W3025655500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32414058" @default.
- W3025655500 hasPublicationYear "2020" @default.
- W3025655500 type Work @default.
- W3025655500 sameAs 3025655500 @default.
- W3025655500 citedByCount "26" @default.
- W3025655500 countsByYear W30256555002020 @default.
- W3025655500 countsByYear W30256555002021 @default.
- W3025655500 countsByYear W30256555002022 @default.
- W3025655500 countsByYear W30256555002023 @default.